{"id":123402,"date":"2017-10-11T21:21:44","date_gmt":"2017-10-12T03:21:44","guid":{"rendered":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/?p=123402"},"modified":"2017-10-11T18:22:07","modified_gmt":"2017-10-12T00:22:07","slug":"dos-vacunas-experimentales-prometen-combatir-ebola","status":"publish","type":"post","link":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/historico\/dos-vacunas-experimentales-prometen-combatir-ebola","title":{"rendered":"Dos vacunas experimentales prometen combatir el \u00e9bola"},"content":{"rendered":"<p>Dos vacunas experimentales contra el virus del \u00e9bola han demostrado ser una promesa para proteger en menos de un a\u00f1o contra la fiebre hemorr\u00e1gica, de acuerdo con los resultados de un amplio ensayo cl\u00ednico publicado el mi\u00e9rcoles.<\/p>\n<p>El reporte en el New England Journal of Medicine hace el primer recuento completo de un esfuerzo a gran escala para probar lo que podr\u00eda ser la primera vacuna contra el \u00e9bola.<\/p>\n<p>El brote del virus altamente contagioso y frecuentemente mortal ha dejado \u00a0m\u00e1s de 11.000 fallecidos, principalmente en Liberia, Guinea y Sierra Leona cuando afect\u00f3 al oeste de \u00c1frica desde finales de 2013 hasta 2016.<\/p>\n<p>La fase II del estudio involucr\u00f3 a 1.500 personas en Monrovia, Liberia. \u00a0Los participantes fueron elegidos al azar para recibir una o dos vacunas para ser probadas o un placebo.<\/p>\n<p>La primera vacuna candidata fue el precursor rVSV-ZEBOV, inicialmente dise\u00f1ado por cient\u00edficos del gobierno de Canad\u00e1 y ahora autorizado a Merck, Sharp y Dohme Corporation.<\/p>\n<p>La segunda vacuna fue cAd3-EBOZ, desarrollada en conjunto por el instituto nacional para alergias y enfermedades infecciosas de Estados Unidos (NIAID) y GlaxoSmithKline<\/p>\n<p>Despu\u00e9s de un mes, 84% de los que recibieron el rVSV-ZEBOV desarrollaron un anticuerpo. El 80% siguieron estando protegidos durante un a\u00f1o.<\/p>\n<p>En el caso de la otra vacuna candidata, cAd3-EBOZ, el 71% desarroll\u00f3 una respuesta de anticuerpo, y 64% sigui\u00f3 teniendo la misma respuesta en un a\u00f1o, cuando el tratamiento termin\u00f3.<\/p>\n<h3>El \u00e9bola una de la enfermedades m\u00e1s mort\u00edferas del mundo<br \/>\n<iframe loading=\"lazy\" src=\"https:\/\/www.youtube.com\/embed\/VKclA9ZMTdA\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/h3>\n<blockquote><p>&#8220;Este tratamiento cl\u00ednico ha aportado valiosa informaci\u00f3n que es esencial para continuar el desarrollo de estas dos vacunas candidatas y que tambi\u00e9n han demostrado que una investigaci\u00f3n bien dise\u00f1ada, \u00e9ticamente s\u00f3lida, se puede dise\u00f1ar durante una epidemia&#8221;, dijo Anthony Fauci, director de NIAID.<\/p>\n<p>&#8220;Una vacuna segura y efectiva ser\u00eda un complemento importante a las cl\u00e1sicas medidas de seguridad p\u00fablica para controlar un inevitable brote de \u00e9bola&#8221;, a\u00f1adi\u00f3.<\/p><\/blockquote>\n<p>Algunas personas que recibieron las vacunas experimentaron &#8220;de leves a moderados efectos que se resuelven, tales como dolor de cabeza, dolor muscular, estado febril y fatiga&#8221;, dijo el reporte.<\/p>\n<blockquote><p>&#8220;Sobre todo, los investigadores dijeron que no se identificaron mayores preocupaciones de seguridad relacionadas con las vacunas. La mayor\u00eda de los asuntos m\u00e9dicos serios reportados durante el proceso fueron debido a la malaria&#8221;.<\/p><\/blockquote>\n<p>La prueba fue conducida como parte de una colaboraci\u00f3n de investigaci\u00f3n cl\u00ednica entre Estados Unidos y Liberia, conocida como Partnership for Research on Ebola Virus in Liberia (PREVAIL).<\/p>\n<p>Unos 15 tipos de vacunas est\u00e1n siendo dise\u00f1adas en el mundo para prevenir esta enfermedad.<\/p>\n<p>Los expertos han dicho que las primeras vacunas podr\u00edan ser aprobadas para usarse en 2018, utilizando un proceso regulatorio expedito.<\/p>\n<p>\u00a9 Agence France-Presse<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dos vacunas experimentales contra el virus del \u00e9bola han demostrado ser una promesa para proteger en menos de un a\u00f1o contra la fiebre hemorr\u00e1gica.<\/p>\n","protected":false},"author":111,"featured_media":123404,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[],"etiqueta":[],"class_list":["post-123402","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dos vacunas experimentales prometen combatir el \u00e9bola<\/title>\n<meta name=\"description\" content=\"Dos vacunas experimentales contra el virus del \u00e9bola han demostrado ser una promesa para proteger en menos de un a\u00f1o contra la fiebre hemorr\u00e1gica.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/historico\/dos-vacunas-experimentales-prometen-combatir-ebola\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dos vacunas experimentales prometen combatir el \u00e9bola\" \/>\n<meta property=\"og:description\" content=\"Dos vacunas experimentales contra el virus del \u00e9bola han demostrado ser una promesa para proteger en menos de un a\u00f1o contra la fiebre hemorr\u00e1gica.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/historico\/dos-vacunas-experimentales-prometen-combatir-ebola\" \/>\n<meta property=\"og:site_name\" content=\"Guatevision\" \/>\n<meta property=\"article:published_time\" content=\"2017-10-12T03:21:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2017\/10\/Captura-de-pantalla-2017-10-11-a-las-6.17.29-p.m..png?quality=82\" \/>\n\t<meta property=\"og:image:width\" content=\"660\" \/>\n\t<meta property=\"og:image:height\" content=\"371\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Andrea Dom\u00ednguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Andrea Dom\u00ednguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/historico\\\/dos-vacunas-experimentales-prometen-combatir-ebola#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/historico\\\/dos-vacunas-experimentales-prometen-combatir-ebola\"},\"author\":{\"name\":\"Andrea Dom\u00ednguez\",\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/#\\\/schema\\\/person\\\/c32981f667022be103abfe48e0b16bca\"},\"headline\":\"Dos vacunas experimentales prometen combatir el \u00e9bola\",\"datePublished\":\"2017-10-12T03:21:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/historico\\\/dos-vacunas-experimentales-prometen-combatir-ebola\"},\"wordCount\":468,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/historico\\\/dos-vacunas-experimentales-prometen-combatir-ebola#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2017\\\/10\\\/Captura-de-pantalla-2017-10-11-a-las-6.17.29-p.m..png\",\"keywords\":[\"\u00e9bola\",\"Salud\"],\"inLanguage\":\"es-GT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/historico\\\/dos-vacunas-experimentales-prometen-combatir-ebola#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/historico\\\/dos-vacunas-experimentales-prometen-combatir-ebola\",\"url\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/historico\\\/dos-vacunas-experimentales-prometen-combatir-ebola\",\"name\":\"Dos vacunas experimentales prometen combatir el \u00e9bola\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/historico\\\/dos-vacunas-experimentales-prometen-combatir-ebola#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/historico\\\/dos-vacunas-experimentales-prometen-combatir-ebola#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2017\\\/10\\\/Captura-de-pantalla-2017-10-11-a-las-6.17.29-p.m..png\",\"datePublished\":\"2017-10-12T03:21:44+00:00\",\"description\":\"Dos vacunas experimentales contra el virus del \u00e9bola han demostrado ser una promesa para proteger en menos de un a\u00f1o contra la fiebre hemorr\u00e1gica.\",\"inLanguage\":\"es-GT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/historico\\\/dos-vacunas-experimentales-prometen-combatir-ebola\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es-GT\",\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/historico\\\/dos-vacunas-experimentales-prometen-combatir-ebola#primaryimage\",\"url\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2017\\\/10\\\/Captura-de-pantalla-2017-10-11-a-las-6.17.29-p.m..png\",\"contentUrl\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2017\\\/10\\\/Captura-de-pantalla-2017-10-11-a-las-6.17.29-p.m..png\",\"width\":660,\"height\":371,\"caption\":\"Dos vacunas experimentales prometen combatir el \u00e9bola\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/#website\",\"url\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/\",\"name\":\"Guatevision\",\"description\":\"\u00a1Enciende Lo Bueno!\",\"publisher\":{\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es-GT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/#organization\",\"name\":\"Guatevision\",\"url\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-GT\",\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2026\\\/04\\\/Diseno-sin-titulo.png\",\"contentUrl\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2026\\\/04\\\/Diseno-sin-titulo.png\",\"width\":1000,\"height\":600,\"caption\":\"Guatevision\"},\"image\":{\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/#\\\/schema\\\/person\\\/c32981f667022be103abfe48e0b16bca\",\"name\":\"Andrea Dom\u00ednguez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-GT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/057379018be24c4b189e7d359c02aa486805c8dd7b433088c60c989acb5a090d?s=96&d=mm&r=g1316cd648fd15fb8e8311665073abf40\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/057379018be24c4b189e7d359c02aa486805c8dd7b433088c60c989acb5a090d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/057379018be24c4b189e7d359c02aa486805c8dd7b433088c60c989acb5a090d?s=96&d=mm&r=g\",\"caption\":\"Andrea Dom\u00ednguez\"},\"url\":\"https:\\\/\\\/prensalibre-com-develop.go-vip.co\\\/guatevision\\\/author\\\/adominguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dos vacunas experimentales prometen combatir el \u00e9bola","description":"Dos vacunas experimentales contra el virus del \u00e9bola han demostrado ser una promesa para proteger en menos de un a\u00f1o contra la fiebre hemorr\u00e1gica.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/historico\/dos-vacunas-experimentales-prometen-combatir-ebola","og_locale":"es_ES","og_type":"article","og_title":"Dos vacunas experimentales prometen combatir el \u00e9bola","og_description":"Dos vacunas experimentales contra el virus del \u00e9bola han demostrado ser una promesa para proteger en menos de un a\u00f1o contra la fiebre hemorr\u00e1gica.","og_url":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/historico\/dos-vacunas-experimentales-prometen-combatir-ebola","og_site_name":"Guatevision","article_published_time":"2017-10-12T03:21:44+00:00","og_image":[{"width":660,"height":371,"url":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2017\/10\/Captura-de-pantalla-2017-10-11-a-las-6.17.29-p.m..png?quality=82","type":"image\/png"}],"author":"Andrea Dom\u00ednguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Andrea Dom\u00ednguez","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/historico\/dos-vacunas-experimentales-prometen-combatir-ebola#article","isPartOf":{"@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/historico\/dos-vacunas-experimentales-prometen-combatir-ebola"},"author":{"name":"Andrea Dom\u00ednguez","@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/#\/schema\/person\/c32981f667022be103abfe48e0b16bca"},"headline":"Dos vacunas experimentales prometen combatir el \u00e9bola","datePublished":"2017-10-12T03:21:44+00:00","mainEntityOfPage":{"@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/historico\/dos-vacunas-experimentales-prometen-combatir-ebola"},"wordCount":468,"commentCount":0,"publisher":{"@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/#organization"},"image":{"@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/historico\/dos-vacunas-experimentales-prometen-combatir-ebola#primaryimage"},"thumbnailUrl":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2017\/10\/Captura-de-pantalla-2017-10-11-a-las-6.17.29-p.m..png","keywords":["\u00e9bola","Salud"],"inLanguage":"es-GT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/historico\/dos-vacunas-experimentales-prometen-combatir-ebola#respond"]}]},{"@type":"WebPage","@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/historico\/dos-vacunas-experimentales-prometen-combatir-ebola","url":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/historico\/dos-vacunas-experimentales-prometen-combatir-ebola","name":"Dos vacunas experimentales prometen combatir el \u00e9bola","isPartOf":{"@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/#website"},"primaryImageOfPage":{"@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/historico\/dos-vacunas-experimentales-prometen-combatir-ebola#primaryimage"},"image":{"@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/historico\/dos-vacunas-experimentales-prometen-combatir-ebola#primaryimage"},"thumbnailUrl":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2017\/10\/Captura-de-pantalla-2017-10-11-a-las-6.17.29-p.m..png","datePublished":"2017-10-12T03:21:44+00:00","description":"Dos vacunas experimentales contra el virus del \u00e9bola han demostrado ser una promesa para proteger en menos de un a\u00f1o contra la fiebre hemorr\u00e1gica.","inLanguage":"es-GT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/historico\/dos-vacunas-experimentales-prometen-combatir-ebola"]}]},{"@type":"ImageObject","inLanguage":"es-GT","@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/historico\/dos-vacunas-experimentales-prometen-combatir-ebola#primaryimage","url":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2017\/10\/Captura-de-pantalla-2017-10-11-a-las-6.17.29-p.m..png","contentUrl":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2017\/10\/Captura-de-pantalla-2017-10-11-a-las-6.17.29-p.m..png","width":660,"height":371,"caption":"Dos vacunas experimentales prometen combatir el \u00e9bola"},{"@type":"WebSite","@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/#website","url":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/","name":"Guatevision","description":"\u00a1Enciende Lo Bueno!","publisher":{"@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es-GT"},{"@type":"Organization","@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/#organization","name":"Guatevision","url":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/","logo":{"@type":"ImageObject","inLanguage":"es-GT","@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/#\/schema\/logo\/image\/","url":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2026\/04\/Diseno-sin-titulo.png","contentUrl":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2026\/04\/Diseno-sin-titulo.png","width":1000,"height":600,"caption":"Guatevision"},"image":{"@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/#\/schema\/person\/c32981f667022be103abfe48e0b16bca","name":"Andrea Dom\u00ednguez","image":{"@type":"ImageObject","inLanguage":"es-GT","@id":"https:\/\/secure.gravatar.com\/avatar\/057379018be24c4b189e7d359c02aa486805c8dd7b433088c60c989acb5a090d?s=96&d=mm&r=g1316cd648fd15fb8e8311665073abf40","url":"https:\/\/secure.gravatar.com\/avatar\/057379018be24c4b189e7d359c02aa486805c8dd7b433088c60c989acb5a090d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/057379018be24c4b189e7d359c02aa486805c8dd7b433088c60c989acb5a090d?s=96&d=mm&r=g","caption":"Andrea Dom\u00ednguez"},"url":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/author\/adominguez"}]}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-content\/uploads\/sites\/2\/2017\/10\/Captura-de-pantalla-2017-10-11-a-las-6.17.29-p.m..png","_links":{"self":[{"href":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-json\/wp\/v2\/posts\/123402","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-json\/wp\/v2\/users\/111"}],"replies":[{"embeddable":true,"href":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-json\/wp\/v2\/comments?post=123402"}],"version-history":[{"count":0,"href":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-json\/wp\/v2\/posts\/123402\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-json\/wp\/v2\/media\/123404"}],"wp:attachment":[{"href":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-json\/wp\/v2\/media?parent=123402"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-json\/wp\/v2\/categories?post=123402"},{"taxonomy":"etiqueta","embeddable":true,"href":"https:\/\/prensalibre-com-develop.go-vip.co\/guatevision\/wp-json\/wp\/v2\/etiqueta?post=123402"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}